BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

312 related articles for article (PubMed ID: 9166837)

  • 21. A novel single-cell proliferation assay shows that long-term culture-initiating cell (LTC-IC) maintenance over time results from the extensive proliferation of a small fraction of LTC-IC.
    Verfaillie CM; Miller JS
    Blood; 1995 Sep; 86(6):2137-45. PubMed ID: 7662962
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ex vivo expansion of megakaryocyte progenitors: effect of various growth factor combinations on CD34+ progenitor cells from bone marrow and G-CSF-mobilized peripheral blood.
    Gehling UM; Ryder JW; Hogan CJ; Hami L; McNiece I; Franklin W; Williams S; Helm K; King J; Shpall EJ
    Exp Hematol; 1997 Oct; 25(11):1125-39. PubMed ID: 9328449
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Ex vivo culture of CD34+/Lin-/DR- cells in stroma-derived soluble factors, interleukin-3, and macrophage inflammatory protein-1alpha maintains not only myeloid but also lymphoid progenitors in a novel switch culture assay.
    Miller JS; McCullar V; Verfaillie CM
    Blood; 1998 Jun; 91(12):4516-22. PubMed ID: 9616147
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Comparison of the content and subpopulations of CD3 and CD34 positive cells in bone marrow harvests and G-CSF-mobilized peripheral blood leukapheresis products from healthy adult donors.
    Hassan HT; Stockschläder M; Schleimer B; Krüger W; Zander AR
    Transpl Immunol; 1996 Dec; 4(4):319-23. PubMed ID: 8972563
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Murine stromal cells counteract the loss of long-term culture-initiating cell potential induced by cytokines in CD34(+)CD38(low/neg) human bone marrow cells.
    Bennaceur-Griscelli A; Tourino C; Izac B; Vainchenker W; Coulombel L
    Blood; 1999 Jul; 94(2):529-38. PubMed ID: 10397720
    [TBL] [Abstract][Full Text] [Related]  

  • 26. CD34(+) cell subsets and long-term culture colony-forming cells evaluated on both autologous and normal bone marrow stroma predict long-term hematopoietic engraftment in patients undergoing autologous peripheral blood stem cell transplantation.
    Lanza F; Campioni D; Moretti S; Dominici M; Punturieri M; Focarile E; Pauli S; Dabusti M; Tieghi A; Bacilieri M; Scapoli C; De Angeli C; Galluccio L; Castoldi G
    Exp Hematol; 2001 Dec; 29(12):1484-93. PubMed ID: 11750108
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Blood-derived autografts collected during granulocyte colony-stimulating factor-enhanced recovery are enriched with early Thy-1+ hematopoietic progenitor cells.
    Haas R; Möhle R; Pförsich M; Fruehauf S; Witt B; Goldschmidt H; Hunstein W
    Blood; 1995 Apr; 85(7):1936-43. PubMed ID: 7535595
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Characterization and quantitation of primitive hematopoietic progenitor cells present in peripheral blood autografts.
    Tong J; Hoffman R; Siena S; Srour EF; Bregni M; Gianni AM
    Exp Hematol; 1994 Sep; 22(10):1016-24. PubMed ID: 8088376
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Long-term hematopoietic culture-initiating cells are more abundant in mobilized peripheral blood grafts than in bone marrow but have a more limited ex vivo expansion potential.
    Srour EF; Bregni M; Traycoff CM; Agüero B; Kosak ST; Hoffman R; Siena S; Gianni AM
    Blood Cells Mol Dis; 1996; 22(1):68-81. PubMed ID: 8807087
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Distinct requirements for optimal growth and In vitro expansion of human CD34(+)CD38(-) bone marrow long-term culture-initiating cells (LTC-IC), extended LTC-IC, and murine in vivo long-term reconstituting stem cells.
    Ramsfjell V; Bryder D; Björgvinsdóttir H; Kornfält S; Nilsson L; Borge OJ; Jacobsen SE
    Blood; 1999 Dec; 94(12):4093-102. PubMed ID: 10590054
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Proliferative responses to interleukin-3 and granulocyte colony-stimulating factor distinguish a minor subpopulation of CD34-positive marrow progenitors that do not express CD33 and a novel antigen, 7B9.
    Litzow MR; Brashem-Stein C; Andrews RG; Bernstein ID
    Blood; 1991 Jun; 77(11):2354-9. PubMed ID: 1710150
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Correlation of colony-forming cells, long-term culture initiating cells and CD34+ cells in apheresis products from patients mobilized for peripheral blood progenitors with different regimens.
    Bender JG; Lum L; Unverzagt KL; Lee W; Van Epps D; George S; Coon J; Ghalie R; McLeod B; Kaizer H
    Bone Marrow Transplant; 1994 Apr; 13(4):479-85. PubMed ID: 7517260
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Dissociation between stem cell phenotype and NOD/SCID repopulating activity in human peripheral blood CD34(+) cells after ex vivo expansion.
    Danet GH; Lee HW; Luongo JL; Simon MC; Bonnet DA
    Exp Hematol; 2001 Dec; 29(12):1465-73. PubMed ID: 11750106
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Self-renewal of primitive human hematopoietic cells (long-term-culture-initiating cells) in vitro and their expansion in defined medium.
    Petzer AL; Hogge DE; Landsdorp PM; Reid DS; Eaves CJ
    Proc Natl Acad Sci U S A; 1996 Feb; 93(4):1470-4. PubMed ID: 8643656
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Differential kinetics of primitive hematopoietic cells assayed in vitro and in vivo during serum-free suspension culture of CD34+ blood progenitor cells.
    Möbest D; Goan SR; Junghahn I; Winkler J; Fichtner I; Hermann M; Becker M; de Lima-Hahn E; Henschler R
    Stem Cells; 1999; 17(3):152-61. PubMed ID: 10342558
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In vitro and in vivo evidence for the long-term multilineage (myeloid, B, NK, and T) reconstitution capacity of ex vivo expanded human CD34(+) cord blood cells.
    Kobari L; Pflumio F; Giarratana M; Li X; Titeux M; Izac B; Leteurtre F; Coulombel L; Douay L
    Exp Hematol; 2000 Dec; 28(12):1470-80. PubMed ID: 11146169
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Characterization of CD34+ peripheral blood cells from healthy adults mobilized by recombinant human granulocyte colony-stimulating factor.
    Tjønnfjord GE; Steen R; Evensen SA; Thorsby E; Egeland T
    Blood; 1994 Oct; 84(8):2795-801. PubMed ID: 7522643
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expansion of mobilized peripheral blood progenitor cells under defined culture conditions rsing CD34+CD71-CD45- cells as a starting population.
    Zech NH; Gunsilius E; Clausen J; Hoflehner E; Hoelzler K; Gastl G; Petzer AL
    J Hematother Stem Cell Res; 2003 Aug; 12(4):367-73. PubMed ID: 12965074
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Ex vivo expansion of enriched peripheral blood CD34+ progenitor cells by stem cell factor, interleukin-1 beta (IL-1 beta), IL-6, IL-3, interferon-gamma, and erythropoietin.
    Brugger W; Möcklin W; Heimfeld S; Berenson RJ; Mertelsmann R; Kanz L
    Blood; 1993 May; 81(10):2579-84. PubMed ID: 7683923
    [TBL] [Abstract][Full Text] [Related]  

  • 40. The low cycling status of mobilized peripheral blood CD34+ cells is not restricted to the more primitive subfraction.
    Croockewit AJ; Raymakers RA; Smeets ME; vd Bosch G; Pennings AH; de Witte TJ
    Leukemia; 1998 Apr; 12(4):571-7. PubMed ID: 9557616
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.